Loading stock data...

Achyut Healthcare Limited

BSE: ACHYUT

BSE
3.65 -0.19 (-4.95%)

Prev Close

3.84

Open Price

3.86

Volume

283,500

Today Low / High

3.65 / 3.86

52 WK Low / High

2.82 / 5

Range

3 - 4

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 3.65, reflecting a change of -0.19 (-4.94792%). The expected target range on the BSE is 3 - 4. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

11 Jul 3.86 -5.44%
10 Jul 3.89 -1.29%
09 Jul 3.90 0.00%
08 Jul 3.95 -4.05%
07 Jul 3.80 0.00%
04 Jul 3.90 -6.41%
03 Jul 3.80 0.00%
02 Jul 3.77 0.80%
01 Jul 3.63 0.00%
30 Jun 3.64 -4.40%
27 Jun 3.53 3.40%
26 Jun 3.54 0.00%
25 Jun 3.55 0.00%
24 Jun 3.39 0.29%
23 Jun 3.32 -2.41%
20 Jun 3.40 -2.65%
19 Jun 3.50 -5.14%
18 Jun 3.80 -8.16%
17 Jun 3.65 0.00%
16 Jun 3.60 0.00%

Achyut Healthcare Limited Graph

Achyut Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Achyut Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 3.65 3.69 3.32 - 4.06
3.72 2.98 - 4.47
3.76 2.63 - 4.89
Bearish Scenario 3.65 3.61 3.25 - 3.97
3.58 2.86 - 4.29
3.54 2.48 - 4.60

Overview of Achyut Healthcare Limited

ISIN

INE0K1401012

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

366,788

Market Cap

859,783,050

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

65.68

DCF

-18

Financial Ratios Every Investor Needs

Stock Rating Details for ACHYUT

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 3.05 Cr 2.87 Cr 0.18 Cr 0.0577 0.00 Cr 0.00 Cr -0.22 Cr 0.55 Cr 0.33 0.72 Cr 0.1797
2024-03-31 6.14 Cr 5.53 Cr 0.60 Cr 0.0985 0.00 Cr 0.00 Cr 0.44 Cr 0.57 Cr 0.41 0.05 Cr 0.0934
2023-03-31 2.54 Cr 2.03 Cr 0.51 Cr 0.1998 0.00 Cr 0.00 Cr -0.28 Cr 0.23 Cr 0.16 -0.26 Cr 0.0909
2022-03-31 3.58 Cr 3.37 Cr 0.21 Cr 0.0586 0.00 Cr 0.00 Cr -0.04 Cr 0.04 Cr 0.04 -0.03 Cr 0.0113
2021-03-31 0.27 Cr 0.24 Cr 0.04 Cr 0.1291 0.00 Cr 0.00 Cr 0.01 Cr 0.01 Cr 0.01 0.01 Cr 0.0271

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.00 Cr 32.59 Cr 1.29 Cr 31.2986 Cr 0.00 Cr -1.00 Cr 0.19 Cr 18.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.2936 Cr
2024-03-31 0.37 Cr 30.95 Cr 0.20 Cr 30.7509 Cr 0.00 Cr -0.37 Cr 0.06 Cr 9.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.2014 Cr
2023-03-31 0.23 Cr 15.34 Cr 0.82 Cr 14.5238 Cr 0.00 Cr -0.23 Cr 0.45 Cr 3.54 Cr 0.31 Cr 0.00 Cr 1.30 Cr 0.8167 Cr
2022-03-31 0.26 Cr 9.94 Cr 0.86 Cr 9.0846 Cr 0.00 Cr -0.26 Cr 0.13 Cr 0.03 Cr 0.47 Cr 0.00 Cr 1.70 Cr 0.8566 Cr
2021-03-31 0.02 Cr 0.47 Cr 0.25 Cr 0.2170 Cr 0.00 Cr -0.02 Cr 0.10 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.2543 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -4.0641 Cr 4.6866 Cr 0.0000 Cr -14.9288 Cr 0.6225 Cr 0.9971 Cr -10.8647 Cr 0.7035 Cr 0.0000 Cr 0.0000 Cr -0.1293 Cr
2024-03-31 -0.3581 Cr -15.2263 Cr 15.7248 Cr -6.3698 Cr 0.1404 Cr 0.3746 Cr -6.0117 Cr 0.5732 Cr 0.0000 Cr 0.0000 Cr 0.2601 Cr
2023-03-31 0.1513 Cr -5.3865 Cr 5.2080 Cr -3.1685 Cr -0.0272 Cr 0.2342 Cr -3.3198 Cr 0.2312 Cr 0.0000 Cr 0.0000 Cr -0.1900 Cr
2022-03-31 -6.8172 Cr -1.7373 Cr 8.7941 Cr -6.8497 Cr 0.2397 Cr 0.2614 Cr -0.0325 Cr 0.0403 Cr 0.0000 Cr 0.0000 Cr -0.0310 Cr
2021-03-31 0.0093 Cr 0.0002 Cr 0.0000 Cr 0.0093 Cr 0.0093 Cr 0.0217 Cr 0.0000 Cr 0.0074 Cr 0.0000 Cr 0.0000 Cr -0.0959 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.92 Cr 0.89 Cr 0.03 Cr 0.0376 -0.13 Cr 0.20 Cr 0.12 0.24 Cr 0.2117
2024-09-30 2.13 Cr 2.14 Cr -0.02 Cr -0.0074 -0.09 Cr 0.35 Cr 0.21 0.48 Cr 0.1659
2024-03-31 4.65 Cr 4.49 Cr 0.16 Cr 0.0348 -0.01 Cr 0.31 Cr 0.22 0.01 Cr 0.0671
2023-09-30 1.48 Cr 1.16 Cr 0.32 Cr 0.2185 0.03 Cr 0.26 Cr 0.19 0.02 Cr 0.1759
2023-03-31 0.81 Cr 0.59 Cr 0.22 Cr 0.2672 -0.29 Cr -0.01 Cr -0.01 0.07 Cr -0.0114

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.00 Cr 0.00 Cr 1.00 Cr 10.87 Cr 0.19 Cr 12.06 Cr 18.22 Cr 32.59 Cr 1.29 Cr
2024-09-30 0.83 Cr 0.00 Cr 0.83 Cr 0.90 Cr 0.06 Cr 16.02 Cr 14.02 Cr 31.93 Cr 0.83 Cr
2024-03-31 0.37 Cr 20.52 Cr 20.89 Cr 0.42 Cr 0.06 Cr 21.47 Cr 9.22 Cr 30.95 Cr 0.20 Cr
2023-09-30 0.13 Cr 0.00 Cr 0.13 Cr 0.25 Cr 0.12 Cr 7.57 Cr 7.09 Cr 15.13 Cr 0.35 Cr
2023-03-31 0.23 Cr 8.46 Cr 8.69 Cr 0.27 Cr 0.45 Cr 10.35 Cr 3.54 Cr 15.34 Cr 0.82 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.20 Cr -1.64 Cr 1.80 Cr 0.00 Cr 0.00 Cr 1.00 Cr 0.83 Cr -4.93 Cr -6.57 Cr
2024-09-30 0.35 Cr -1.52 Cr 1.98 Cr 0.00 Cr 0.46 Cr 0.83 Cr 0.37 Cr -5.93 Cr -7.46 Cr
2024-03-31 0.31 Cr -0.47 Cr -15.01 Cr 15.72 Cr 0.24 Cr 0.37 Cr 0.13 Cr -2.13 Cr -2.60 Cr
2023-09-30 0.26 Cr 0.41 Cr -0.51 Cr 0.00 Cr -0.10 Cr 0.13 Cr 0.23 Cr -3.88 Cr -3.48 Cr
2023-03-31 -0.01 Cr -0.79 Cr -5.21 Cr 5.21 Cr -0.40 Cr -0.40 Cr 0.00 Cr -3.32 Cr -4.11 Cr

Splits History

Date Label Split Ratio
2024-12-10 December 10, 24 10:1
2023-05-03 May 03, 23 3:2

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,672.00 ₹4,011,596,160,000.00 ₹1,298,300.00
Divi's Laboratories Limited DIVISLAB ₹6,835.00 ₹1,814,480,615,000.00 ₹224,031.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,314.20 ₹1,121,674,419,000.00 ₹344,196.00
Mankind Pharma Limited MANKIND ₹2,578.30 ₹1,064,138,561,908.00 ₹2,780,363.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,254.70 ₹1,044,010,449,778.00 ₹895,308.00
Zydus Lifesciences Limited ZYDUSLIFE ₹979.60 ₹985,702,908,000.00 ₹921,030.00
Lupin Limited LUPIN ₹1,894.70 ₹865,339,805,200.00 ₹1,511,045.00
Aurobindo Pharma Limited AUROPHARMA ₹1,124.80 ₹653,286,089,600.00 ₹1,058,782.00
Glenmark Pharmaceuticals Limited GLENMARK ₹2,181.10 ₹615,508,601,100.00 ₹15,678,334.00
Alkem Laboratories Limited ALKEM ₹4,806.70 ₹574,713,085,500.00 ₹183,070.00
Laurus Labs Limited LAURUSLABS ₹790.20 ₹426,117,720,600.00 ₹1,475,669.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Cohance Lifesciences Limited COHANCE ₹1,017.95 ₹389,434,085,794.00 ₹322,114.00
Ipca Laboratories Limited IPCALAB ₹1,449.60 ₹367,769,318,400.00 ₹119,065.00
Ajanta Pharma Limited AJANTPHARM ₹2,626.50 ₹328,081,368,000.00 ₹236,895.00
Wockhardt Limited WOCKPHARMA ₹1,757.10 ₹285,491,850,900.00 ₹3,159,181.00
Piramal Enterprises Limited PEL ₹1,217.50 ₹275,980,465,000.00 ₹2,508,249.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,608.60 ₹251,036,507,400.00 ₹444,444.00
Eris Lifesciences Limited ERIS ₹1,709.80 ₹232,869,630,600.00 ₹106,770.00
AstraZeneca Pharma India Limited ASTRAZEN ₹9,241.50 ₹231,037,500,000.00 ₹20,847.00
Alembic Pharmaceuticals Limited APLLTD ₹976.60 ₹191,963,425,800.00 ₹60,016.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,165.70 ₹185,673,861,700.00 ₹144,076.00
NATCO Pharma Limited NATCOPHARM ₹961.80 ₹172,267,998,000.00 ₹1,353,979.00
Neuland Laboratories Limited NEULANDLAB ₹12,301.00 ₹157,820,599,900.00 ₹74,663.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,023.30 ₹153,794,472,610.00 ₹35,929.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹469.00 ₹113,800,036,000.00 ₹331,193.00
Procter & Gamble Health Limited PGHL ₹5,755.50 ₹95,537,846,700.00 ₹23,112.00
Shilpa Medicare Limited SHILPAMED ₹896.75 ₹87,693,989,575.00 ₹154,034.00
Aarti Pharmalabs Limited AARTIPHARM ₹927.20 ₹84,036,419,664.00 ₹291,915.00
Strides Pharma Science Limited STAR ₹887.80 ₹81,822,045,060.00 ₹428,094.00
FDC Limited FDC ₹501.35 ₹81,624,793,500.00 ₹72,209.00
Suven Life Sciences Limited SUVEN ₹276.63 ₹60,325,810,620.00 ₹285,602.00
Sun Pharma Advanced Research Company Limited SPARC ₹159.34 ₹51,709,335,480.00 ₹1,252,722.00
Innova Captab Limited INNOVACAP ₹875.40 ₹50,094,703,722.00 ₹46,543.00
Sequent Scientific Limited SEQUENT ₹184.32 ₹46,136,217,600.00 ₹343,582.00
Aarti Drugs Limited AARTIDRUGS ₹473.60 ₹43,225,472,000.00 ₹158,284.00
Hikal Limited HIKAL ₹340.50 ₹41,983,990,500.00 ₹164,468.00
RPG Life Sciences Limited RPGLIFE ₹2,526.20 ₹41,780,821,800.00 ₹17,230.00
Unichem Laboratories Limited UNICHEMLAB ₹590.85 ₹41,599,266,930.00 ₹17,355.00
Orchid Pharma Limited ORCHPHARMA ₹718.30 ₹36,431,529,530.00 ₹55,088.00
Gufic Biosciences Limited GUFICBIO ₹349.05 ₹35,002,035,900.00 ₹50,065.00
Morepen Laboratories Limited MOREPENLAB ₹62.67 ₹34,340,277,180.00 ₹1,978,828.00
Solara Active Pharma Sciences Limited SOLARA ₹664.85 ₹32,014,522,050.00 ₹589,436.00
Indoco Remedies Limited INDOCO ₹326.45 ₹30,114,326,955.00 ₹174,646.00
Alembic Limited ALEMBICLTD ₹117.26 ₹30,110,257,203.00 ₹332,328.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹91.18 ₹26,763,791,860.00 ₹1,225,212.00

Key Executives

Executive Officer
Mr. Piyush Jagdishbhai Madhwan

Gender: male

Year Born: 1990

Executive Officer
Trupti B. Kacha

Gender: Not Specified

Year Born: 1978

Executive Officer
Deepak Natvarlal Rana

Gender: Not Specified

Year Born:

Executive Director
Ms. Amisha Jigen Modi

Gender: female

Year Born: 1970

Executive Officer
Mr. Mevada Premchandabhai

Gender: male

Year Born: 1980

Executive Officer
Vikram B. Thakor

Gender: Not Specified

Year Born: 1977

Executive Officer
Mr. Pravinbhai Somabhai Shrimal

Gender: male

Year Born: 1972

MD, Chief Financial Officer & Executive Director
Mr. Jigen Jagdishbhai Modi

Gender: male

Year Born: 1969

FAQs about Achyut Healthcare Limited

Who is the CEO of the company?

The CEO is Jigen Jagdishbhai Modi.

What is the current market price of the stock?

The current price is ₹3.65.

What is the 52-week price range?

The range is ₹2.82-5.

What is the market capitalization of the company?

The market capitalization is ₹85.98 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 11.21.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Achyut Healthcare Limited (ISIN: INE0K1401012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹85.98 crores and an average daily volume of 366,788 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.